Kuros Biosciences AG (KURN)

Currency in CHF
23.060
+0.660(+2.95%)
Closed·
KURN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.30023.460
52 wk Range
17.69034.200
Key Statistics
Bid/Ask
22.90 / 23.40
Prev. Close
22.4
Open
22.42
Day's Range
22.3-23.46
52 wk Range
17.69-34.2
Volume
126.74K
Average Volume (3m)
182.8K
1-Year Change
-13.8266%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KURN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
33.865
Upside
+46.85%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Kuros Biosciences AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 33.865
(+46.85% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy33.00+43.10%-New CoverageJul 29, 2026

Earnings

Latest Release
Mar 10, 2026
EPS / Forecast
0.10 / --
Revenue / Forecast
82.58M / 38.1M
EPS Revisions
Last 90 days

KURN Income Statement

Compare KURN to Peers and Sector

Metrics to compare
KURN
Peers
Sector
Relationship
P/E Ratio
458.3x17.8x−0.4x
PEG Ratio
3.060.300.00
Price/Book
13.4x2.6x2.6x
Price / LTM Sales
7.7x2.3x3.1x
Upside (Analyst Target)
43.8%5.1%47.5%
Fair Value Upside
Unlock15.3%5.9%Unlock

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
6.28M15.83%140.65M
Other Institutional Investors
471.21K1.19%10.56M
Public Companies & Retail Investors
32.92M82.99%737.45M
Total
39.67M100.00%888.65M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.3.25%1,287,54228,841
UBS Asset Management AG2.86%1,136,06725,448

People Also Watch

6.51
IDIA
+9.77%
15.37
SIGNC
-0.58%
52.95
GF
+0.86%
78.50
SFZN
-0.44%
409.80
YPSN
+2.45%

FAQ

What Is the Kuros Biosciences (KURN) Stock Price Today?

The Kuros Biosciences stock price today is 23.060 CHF.

What Stock Exchange Does Kuros Biosciences Trade On?

Kuros Biosciences is listed and trades on the Switzerland Stock Exchange.

What Is the Stock Symbol for Kuros Biosciences?

The stock symbol for Kuros Biosciences is "KURN."

What Is the Kuros Biosciences Market Cap?

As of today, Kuros Biosciences market cap is 914.830M CHF.

What Is Kuros Biosciences's Earnings Per Share (TTM)?

The Kuros Biosciences EPS (TTM) is 0.060.

When Is the Next Kuros Biosciences Earnings Date?

Kuros Biosciences will release its next earnings report on Oct 16, 2025.

From a Technical Analysis Perspective, Is KURN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kuros Biosciences Stock Split?

Kuros Biosciences has split 8 times.

How Many Employees Does Kuros Biosciences Have?

Kuros Biosciences has 178 employees.

What is the current trading status of Kuros Biosciences (KURN)?

As of Aug 12, 2026, Kuros Biosciences (KURN) is trading at a price of 23.060 CHF, with a previous close of 22.400 CHF. The stock has fluctuated within a day range of 22.300 CHF to 23.460 CHF, while its 52-week range spans from 17.690 CHF to 34.200 CHF.

What Is Kuros Biosciences (KURN) Price Target According to Analysts?

The average 12-month price target for Kuros Biosciences is 33.865 CHF, with a high estimate of 38 CHF and a low estimate of 32 CHF. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +46.85% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.